Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 123
2021 240
2022 245
2023 130
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

687 results

Results by year

Filters applied: . Clear all
Page 1
Scabies in infants and children - a narrative review.
Chiriac AE, Diaconeasa A, Miulescu R, Wollina U. Chiriac AE, et al. Eur J Pediatr. 2024 Mar 27. doi: 10.1007/s00431-024-05535-1. Online ahead of print. Eur J Pediatr. 2024. PMID: 38536458 Review.
Polymerase chain reaction (PCR) is less sensitive and specific than microscopy of skin scrapings. Treatment of choice is topical permethrin 5%. Ivermectin is the only oral drug FDA-approved for scabies. It should be used in cases non-responsive to topical therapy and in ca …
Polymerase chain reaction (PCR) is less sensitive and specific than microscopy of skin scrapings. Treatment of choice is topical permethrin …
Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study.
Amaral LJ, Jada SR, Ndjanfa AK, Carter JY, Abd-Elfarag G, Okaro S, Logora MY, Bol YY, Lakwo T, Fodjo JNS, Colebunders R. Amaral LJ, et al. PLoS Negl Trop Dis. 2024 Mar 21;18(3):e0012059. doi: 10.1371/journal.pntd.0012059. Online ahead of print. PLoS Negl Trop Dis. 2024. PMID: 38512994 Free article.
The incidence of epilepsy, including pNS, was analysed using 95% confidence intervals (CIs). Data on ivermectin intake and onchocerciasis-associated manifestations (itching and blindness) were collected. ...Coverage of CDTI was suboptimal, reaching only 64.0% of participan …
The incidence of epilepsy, including pNS, was analysed using 95% confidence intervals (CIs). Data on ivermectin intake and onchocerci …
Identification of inositol monophosphatase as a broad-spectrum antiviral target of ivermectin.
Jitobaom K, Peerapen P, Boonyuen U, Meewan I, Boonarkart C, Sirihongthong T, Thongon S, Thongboonkerd V, Auewarakul P. Jitobaom K, et al. J Med Virol. 2024 Mar;96(3):e29552. doi: 10.1002/jmv.29552. J Med Virol. 2024. PMID: 38511598
Ivermectin has broad-spectrum antiviral activities. Despite the failure in clinical application of COVID-19, it can serve as a lead compound for the development of more effective broad-spectrum antivirals, for which a better understanding of its antiviral mec
Ivermectin has broad-spectrum antiviral activities. Despite the failure in clinical application of COVID-19, it can ser
Ivermectin for treatment of COVID-19: A systematic review and meta-analysis.
Song Z, Shi S, Zhang Y. Song Z, et al. Heliyon. 2024 Mar 11;10(6):e27647. doi: 10.1016/j.heliyon.2024.e27647. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38510038 Free PMC article.
The effect of ivermectin (IVM) in treating coronavirus disease 2019 (COVID-19) is still controversial, yet the drug has been widely used in the world. ...There were significant differences in MV requirement (RR 0.67, 95% CI 0.47-0.96) and AEs (RR 0.87, 95% CI …
The effect of ivermectin (IVM) in treating coronavirus disease 2019 (COVID-19) is still controversial, yet the drug has …
Drugs and natural products for the treatment of COVID-19 during 2020, the first year of the pandemic.
Jaimes-Castelán EG, González-Espinosa C, Magos-Guerrero GA, Arrieta-Cruz I, Jiménez-Estrada M, Reyes-Chilpa R, Castillo-Arellano JI. Jaimes-Castelán EG, et al. Bol Med Hosp Infant Mex. 2024;81(1):53-72. doi: 10.24875/BMHIM.23000016. Bol Med Hosp Infant Mex. 2024. PMID: 38503318 English.
This work aimed to show which treatments showed efficacy against coronavirus disease 2019 (COVID-19); therefore, the results of 37 clinical trials started in 2020 and completed in 2021 are reviewed and discussed here. ...We found 34 drugs, one vitamin, and one herba …
This work aimed to show which treatments showed efficacy against coronavirus disease 2019 (COVID-19); therefore, the results o …
Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proof.
Aboras SI, Megahed AA, El-Yazbi F, Maher HM. Aboras SI, et al. BMC Chem. 2024 Mar 7;18(1):50. doi: 10.1186/s13065-024-01147-w. BMC Chem. 2024. PMID: 38454503 Free PMC article.
The cutting-edge combination of fluvoxamine (FVM) and ivermectin (IVM) has been presented as a proposed dosage form for the treatment of COVID-19 infections in early diagnosed patients. ...
The cutting-edge combination of fluvoxamine (FVM) and ivermectin (IVM) has been presented as a proposed dosage form for the treatment …
Wheel Replacing Pyramid: Better Paradigm Representing Totality of Evidence-Based Medicine.
Aldous C, Dancis BM, Dancis J, Oldfield PR. Aldous C, et al. Ann Glob Health. 2024 Feb 29;90(1):17. doi: 10.5334/aogh.4341. eCollection 2024. Ann Glob Health. 2024. PMID: 38435471 Free PMC article.
For the case study, PubMed was used by searching for peer-reviewed reports containing "ivermectin" and either "covid" or "sars" in the title. Reports were filtered for those using ivermectin-based protocols in the treatment of COVID-19. ...A T-EBM Whee …
For the case study, PubMed was used by searching for peer-reviewed reports containing "ivermectin" and either "covid" or "sars" in th …
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.
Hayward G, Yu LM, Little P, Gbinigie O, Shanyinde M, Harris V, Dorward J, Saville BR, Berry N, Evans PH, Thomas NPB, Patel MG, Richards D, Hecke OV, Detry MA, Saunders C, Fitzgerald M, Robinson J, Latimer-Bell C, Allen J, Ogburn E, Grabey J, de Lusignan S, Hobbs FR, Butler CC; PRINCIPLE Trial Collaborative Group. Hayward G, et al. J Infect. 2024 Feb 29;88(4):106130. doi: 10.1016/j.jinf.2024.106130. Online ahead of print. J Infect. 2024. PMID: 38431155 Free article.
BACKGROUND: The evidence for whether ivermectin impacts recovery, hospital admissions, and longer-term outcomes in COVID-19 is contested. ...INTERPRETATION: Ivermectin for COVID-19 is unlikely to provide clinically meaningful improvement …
BACKGROUND: The evidence for whether ivermectin impacts recovery, hospital admissions, and longer-term outcomes in COVID-19
Inefficacious drugs against covid-19: analysis of sales, tweets, and search engines.
Brito Junior I, Saraiva FA, Bruno NC, Silva RFD, Hino CM, Yoshizaki HTY. Brito Junior I, et al. Rev Saude Publica. 2024 Feb 26;58:06. doi: 10.11606/s1518-8787.2024058005413. eCollection 2024. Rev Saude Publica. 2024. PMID: 38422280 Free PMC article.
OBJECTIVE: Assess the correlation between the sales of two drugs with no proven efficacy against covid-19, ivermectin and chloroquine, and other relevant variables, such as Google searches, number of tweets related to these drugs, number of cases and deaths r …
OBJECTIVE: Assess the correlation between the sales of two drugs with no proven efficacy against covid-19, ivermectin a …
Knowledge, attitude and prevalence of ivermectin use as coronavirus disease treatment: A crosssectional study among a Malaysian population.
Filza Nur Athirah T, Aina Amanina AJ, Nor Safwan Hadi NA. Filza Nur Athirah T, et al. Malays Fam Physician. 2024 Jan 6;19:2. doi: 10.51866/oa.415. eCollection 2024. Malays Fam Physician. 2024. PMID: 38371720 Free PMC article.
There is no approval of ivermectin as COVID-19 treatment by the Food and Drug Administration, and the adverse effects of the drug are alarming. ...Conversely, no socio-demographic characteristics were significantly associated with the prevalence of ivermec
There is no approval of ivermectin as COVID-19 treatment by the Food and Drug Administration, and the adverse effects o …
687 results